CJ CheilJedang CEO Kyung Shik Sohn: "Actively Fostering Healthcare... Leading the Next-Generation Wellness Market"

CJ CheilJedang Holds Annual General Meeting on the 24th

"K-Food's Global Expansion Trend

Pursuing Scaling Up of Global Strategic Products"

Yoon Seokhwan Appointed as Inside Director of Bio Division

At the CJ CheilJedang 19th Annual General Meeting of Shareholders held on the 24th at the CJ Human Resources Center in Jung-gu, Seoul, Yoon Seok-hwan, Head of the Bio Division, is delivering a greeting. Provided by CJ CheilJedang.

Kyung Shik Sohn, CEO of CJ CheilJedang, emphasized, "In line with population aging and the wellness trend, we will actively foster high value-added healthcare sectors to create new sources of revenue and take the lead in next-generation wellness markets."

At the 19th Annual General Meeting of Shareholders held on the 24th at the CJ Talent Center in Jung-gu, Seoul, CEO Sohn stated, "We will make this year the 'first year of growth and innovation' to firmly establish ourselves as a truly global top-tier company."

Regarding this year's key priorities, he said, "Based on the global spread of K-food, we will accelerate the growth of our global strategic products. By concentrating our marketing and R&D capabilities, we will pursue the scaling up of our global strategic products, strengthen localization strategies tailored to each country's food culture, and enhance premium branding. We will focus our business capabilities and resources on expanding into new global territories."

However, CEO Sohn predicted that the business environment for CJ CheilJedang's core food division would not be favorable for the time being. He therefore announced plans to optimize the business structure with a focus on future growth.

He added, "In the domestic market, we will strengthen digital marketing and expand growth channels such as online, convenience stores, and warehouse-type outlets. We will rapidly implement structural innovation centered on organization, workforce, and infrastructure to reinforce a sustainable integrated online-offline growth structure."

He continued, "In the global market, growth will be accelerated through region-specific strategies. In the Americas, we will leverage leadership in core products like pizza and capitalize on the K-Wave. In Europe, we will maximize manufacturing competitiveness for key products such as dumplings and chicken, using our new Hungarian base as a hub. In China and Japan, we aim to balance profitability and growth through locally customized business structures, while in Asia-Pacific and new territories, we will actively drive global performance by targeting the halal market and launching core products tailored to each country."

CEO Sohn explained that in the bio business sector, the company will lay the foundation for a new leap forward by streamlining the feed amino acids business and establishing new business models. In the biodegradable plastics business, the company plans to achieve scaling up by expanding commercialization centered on its brands.

Despite a decline in profits last year, CJ CheilJedang has set its annual dividend at the same level as the previous year, including already paid quarterly dividends. The company plans to pay 6,000 won per common share and 6,050 won per preferred share. CJ CheilJedang recorded sales of 27.3426 trillion won last year, a 0.4% increase from the previous year, while operating profit decreased by 15% to 1.2336 trillion won compared to the previous year.

Meanwhile, at the Annual General Meeting on this day, CJ CheilJedang approved the appointment of Yoon Seokhwan, Head of the Bio Division, as an inside director. In addition, agenda items such as approval of the 19th financial statements, amendments to the articles of incorporation, appointment of directors, appointment of outside directors as members of the audit committee, and approval of the remuneration limit for directors were all passed as originally proposed.

This content was produced with the assistance of AI translation services.